Business Segments Stratec SE Deutsche Boerse AG
Stocks
SBS
DE000STRA555
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.00 EUR | +1.82% |
|
-0.21% | -14.22% |
| 07-15 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reaffirms its Neutral rating | ZD |
| 07-03 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg gives a Buy rating | ZD |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Automation Solutions for Highly Regulated Laboratory | - | - | 262M | 258M | 251M | |||||
Total Assets | - | - | 467M | 445M | 426M | |||||
Interest Expense | - | - | -3.9M | -5.81M | -4.1M | |||||
Income Tax Expense | - | - | 5.16M | 5.99M | 5.09M | |||||
CAPEX | - | - | -8.34M | -9.88M | -9.28M | |||||
EBT | - | - | 18.23M | 22.01M | 4.85M | |||||
Gross Profit | - | - | 64.84M | 76.39M | 64.22M | |||||
D&A | - | - | 14.17M | 16.04M | 15.37M | |||||
Net Income | - | - | 13.07M | 16.02M | -242K | |||||
Smart Consumables | 19.73M | 24.45M | - | - | - | |||||
Total Assets | 51.12M | 34.18M | - | - | - | |||||
Interest Expense | -702K | -703K | - | - | - | |||||
CAPEX | -1.91M | -3.21M | - | - | - | |||||
EBITDA | 2.59M | 4.72M | - | - | - | |||||
D&A | 4.02M | 3.81M | - | - | - | |||||
Operating Income | 525K | 2.51M | - | - | - | |||||
Diatron (Includes Service Parts and Consumables Allocable to Business Unit) | 73.86M | 59.89M | - | - | - | |||||
Total Assets | 283M | 76.02M | - | - | - | |||||
Interest Expense | -2.18M | -2.22M | - | - | - | |||||
CAPEX | -4.09M | -8.28M | - | - | - | |||||
EBITDA | 20.94M | 13.75M | - | - | - | |||||
D&A | 5.45M | 3.37M | - | - | - | |||||
Operating Income | 19.45M | 12.18M | - | - | - | |||||
Reconciliation | -9.98M | -7.64M | - | - | - | |||||
Total Assets | -337M | -113M | - | - | - | |||||
Interest Expense | 2.4M | 2.39M | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBITDA | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Instrumentation (Includes Spare Parts and Consumables Attributable to This Business Unit) | 204M | 198M | - | - | - | |||||
Total Assets | 372M | 400M | - | - | - | |||||
Interest Expense | -959K | -1.36M | - | - | - | |||||
CAPEX | -14.86M | -13.56M | - | - | - | |||||
EBITDA | 43.08M | 40.11M | - | - | - | |||||
D&A | 8.78M | 9.75M | - | - | - | |||||
Operating Income | 34.3M | 30.36M | - | - | - | |||||
Healthcare Industry Software | ||||||||||
Other Segments | - | - | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBITDA | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
European Union | - | 110M | 92.12M | 82.97M | 102M | |||||
United States | 96.06M | 78.63M | 93.04M | 120M | 101M | |||||
Total Assets | - | - | - | 37.1M | 31.46M | |||||
Total Assets | - | - | - | 36.9M | 34.82M | |||||
Total Assets | - | - | - | 23.28M | 21.9M | |||||
Total Assets | - | - | - | 7.33M | 6.93M | |||||
Germany | 46.4M | 56.79M | 51.53M | 27.82M | 30.03M | |||||
Total Assets | 73.51M | 76.84M | 80.56M | 80.38M | 80.82M | |||||
Other | 26.83M | 29.39M | 25.23M | 26.69M | 17.54M | |||||
Total Assets | 83.32M | 85.43M | 117M | 9.12M | 8.72M | |||||
UK | 1.53M | - | - | - | - | |||||
European Union (Except UK) | 117M | - | - | - | - |
- Stock Market
- Stocks
- SBS Stock
- SBS Stock
- Financials Stratec SE
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















